Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Pre-order your Brochure
Reserve your place

2nd Annual eyeforpharma Medical Affairs USA 10 - 11 April, 2018|Philadelphia, US

2017's Agenda

Pharma is changing fast. Payers, prescribers and stakeholders demand holistic thinking, Real World Evidence and new, agile strategies. Medical Affairs departments are being expanded and re-tasked to meet these needs and shepherd Pharma companies into the future. At this landmark conference, we will explore the pivotal role of Medical Affairs and how you will help shape decisions across your entire organisation.

Philadelphia Timed Agenda – Click Here
*Gain access to the sessions at eyeforpharma Philadelphia*

Day One

Keynote Opening
8:30AM - 8:35AM
Welcome Address

eyeforpharma Paul Simms Chairman eyeforpharma

8:35AM - 9:15AM
Ready for Healthcare Leadership - How Pharma embraces a New Customer Engagement Paradigm
  • Discuss industry implications of the shift to value-based care and learn how pioneering leaders position pharma companies to thrive in the complexity of the future healthcare ecosystem
  • Define the value of pharmaceutical innovation through the lens of the patient journey and lay the foundation to partner with healthcare delivery to support patient population management
  • Explore how to demonstrate transparency to build trust with patients, physicians and politicians

Otsuka Kabir Nath President & CEO Otsuka North America

Shire Perry Sternberg EVP & Head U.S. Commercial Shire

Kaiser Permanente Andrew McCulloch President- Kaiser Foundation Health Plan & Hospitals Northwest Region Kaiser Permanente

Moderator: National Health Council Marc Boutin CEO National Health Council

9:15AM - 9:45AM
Real Human Connection – A healthcare marketer’s new superpower
  • In today’s world, it appears that everything is “social” and “connected,” yet what does “being connected” even mean when it comes to healthcare?
  • Learn from real-world examples of how different healthcare stakeholders connect around patients and their needs

Shire Eric Cline Director Marketing US Neuroscience Business Unit Shire

UCB Dakar De La Cruz Senior Brand Manager Epilepsy Patients Initiatives UCB

AstraZeneca Pharmaceuticals Lise Hall Associate Director of Consumer Marketing Lung Cancer Franchise AstraZeneca Pharmaceuticals

Moderator: Snow Companies Chemelle Evans Vice President Snow Companies

9:45AM - 10:00AM
Awards Finalist Announcement: Most Valuable Patient Initiative
10:00AM - 10:30AM
Exhibition & Networking Coffee Break
10:30AM - 11:00AM
Patient Centricity as a Journey: Spearheading Cultural Change in a Global Pharma Organization
  • Hear leadership lessons and best practices on how to drive transformative cultural change, break organizational silos and foster a company-wide ethos of “patients first”
  • When vision meets determination: How can you initiate the success of a patient-focused mindset through a mix of top-down motivation and bottom-up actions?
  • Learn about the relationship between business growth and patient focus and how it impacts your stakeholder management

Merck Julie Gerberding EVP & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health Merck

11:00AM - 11:30AM
Delivering Impact through Customer-Centric Partnerships

The U.S. healthcare marketplace has undergone dramatic changes, including the shift in power away from physicians, and towards large payers and provider systems as they take on more risk and want demonstrable value. This has made pharma’s traditional model less relevant.

In response, pharmaceutical companies must reinvent the way they go to market by focusing on the unique needs of complex corporate customers to create a customer-centric engagement strategy, including:

  • Customer insights for complete local healthcare markets, including all stakeholders’ needs and interactions
  • Marketing and value propositions that stress the impact on health and value metrics
  • Expansion to dozens of roles that can work as a coordinated team
  • Objectives that align multiple functions in the organization

ZS Associates Partap Khedkar Principal ZS Associates

ZS Associates Paul Darling Principal ZS Associates

11:30AM - 12:10PM
Accelerating Bio-Pharmaceutical Innovation in the 21st Century: An Emergent Ecosystem
  • From Cambridge to San Diego: Hear life science leaders who shape the collaborative ecosystem that is shaping up for faster development of tomorrow’s cures amongst multiple stakeholders
  • “Distributed” Research: Harness the power of partnerships to accelerate development, standardize frameworks and build open platforms for the in- and outflow of knowledge between partners
  • Take charge of Innovation: Explore novel approaches to finance biopharmaceutical innovation for high-cost, breakthrough medications

Johnson & Johnson Melinda Richter Head JLabs Johnson & Johnson

Novo Nordisk Eddie Williams Former SVP BioPharmaceutical Novo Nordisk

Transcelerate Dalvir Gill CEO Transcelerate

12:10PM - 1:25PM
Exhibition & Networking Lunch Break
1:25PM - 1:35PM
Awards Finalist Announcement: Most Valuable HCP Initiative
1:35PM - 2:05PM
It's more than 'the Right Thing to Do': Embrace Patient Centricity as your Key Commercial Focus
  • Learn about the relationship between business growth and patient focus and how the sweet spot impacts your stakeholder management
  • Steer your company's patient focus out of the buzzword land through measurement, cultural training, and executive commitment
  • Explore metrics to reveal the impact of patient-centric initiatives, including performance indicators that can guide your line management
  • Understand where to expand your business offering and customer perspective to truly service patients with everything you do

Pfizer Innovative Health Andy Schmeltz Senior Vice President of Patient & Health Impact Pfizer Innovative Health

2:05PM - 3:10PM
Pharma-Only Workshops
3:10PM - 3:30PM
Exhibition & Networking Coffee Break
Medical Affairs
Define the New Medical Model
3:30PM - 3:35PM
Chairman Opening
3:35PM - 4:00PM
Make medical the link between R&D and commercial
  • Discuss how and when Medical should become involved in early-stage projects and Life-cycle management
  • Explore the important role of patient centricity as an essential foundational component for collaboration
  • Identify opportunities to improve partnership effectiveness

Sanofi Genzyme Paul Rowe Vice President, Global Medical Affairs Head, Airway/Respiratory Sanofi Genzyme

4:00PM - 4:30PM
The Good, The Bad and the Necessary
  • A review of success rates in recent drug launches
  • Look at where launches haven’t gone well and where RWE could have played a role in mitigating this… The Bad
  • Building an Integrated Medical Plan to prepare for success. “Begin with the End in Mind”… The Good
  • The resource versus demand challenge and the consequent benefit of outsourcing… The Necessary

INC Research Janet Baldwin Vice President, Real World and Late Phase INC Research

4:30PM - 5:10PM
Panel: Define a new Medical operating model to align with Commercial, Market Access and R&D
  • Understand what internal stakeholders think about their relationship with Medical and the emergence of Medical as a strategic partner
  • Where should medical reside - independently, within R&D, or Commercial?
  • Create a reporting and management structure that meets the needs for a new approach to Medical Affairs

GlaxoSmithKline Kate Knobil Chief Medical Officer, Pharmaceuticals GSK

Medical Affairs Professional Society Kirk Shepard President Medical Affairs Professional Society;
Eisai Pharma & Senior Vice President, Head of Global Medical Affairs Oncology Eisai Pharma

Amgen Rosh Dias Vice President, Global Scientific Affairs Amgen

5:10PM - 5:40PM
Pharma Collaboration for Transparent Medical Information
  • HCPs need quick, relevant, accurate, scientifically-balanced medical information to enhance patient care
  • phactMI is a consortium comprised of MI departments of multiple pharmaceutical companies to address this need
  • phactMI.org provides an easy access “one stop” to information on drug interactions, stability/compatibility, and dosage and administration… and HCPs can contact and engage with dedicated MI specialists

phactMI Patrick Reilly CEO phactMI

5:40PM - 6:05PM
The Doctor is in (and out): Medical Affairs’ evolution from an internal role to an external one
  • Understand the evolving role of medical affairs in pharma
  • Explore the benefits and challenges of using internal medical spokespeople for external communications
  • Embrace the potential for medical affairs’ new role through a case study

GlaxoSmithKline Leonard Friedland Vice President, Director Scientific Affairs and Public Policy, Vaccines North America GSK

6:05PM - 7:30PM
Exhibition & Networking, Awards Nomination Finalists: Lifetime Achievement Award

Day Two

Medical Affairs
8:30AM
-
8:35AM
Chairman Opening
8:35AM
-
9:00AM
Collaborate with Commercial to create a compliant and patient-focused Medical Affairs strategy
  • Identify appropriate cross-functional stakeholders for coordination and alignment
  • Ensure independence and integrity of Medical Affairs and Commercial functions
  • Enable effective and compliant information sharing/communication

Astellas Pharma Shontelle Dodson Vice President, Medical Excellence/Medical Affairs Global Astellas

Astellas Karen Lowney Executive Director, Global Compliance, Privacy & Transparency Astellas

Recruit and Manage the new Medical Affairs
9:00AM
-
9:30AM
Hire the right skillsets for the new medical affairs paradigm
  • Define recruitment and training strategies to meet your medical affairs needs
  • Build soft business skills within medical specialist talent
  • Create a team that can execute RWE and data-centric engagement strategies

- Stanislev Glezer former Vice President, Medical Affairs Novo Nordisk

9:30AM
-
9:55AM
The Competent Medical Affairs Professional
  • Discuss the emerging role of professional competencies (applied knowledge, skills and behaviors) in bridging the business needs with the scientific rigor of the medicines development process
  • Understand how to benchmark the proposed competency profiles in medical affairs
  • Appreciate the value of a multi-sectorial collaboration (academia, professional associations, pharmaceutical industry) to improving performance in the Medical Affairs function

IFAPP Honorio Silva President IFAPP

9:55AM
-
10:20AM
How to create a patient-centric Medical Affairs unit
  • Define best practice to engage patients, understand their needs and create patient-centric medical information exchange
  • How to work progressively with patients to gather data
  • Can Medical Affairs become the patient centricity function?

Pfizer Roslyn Schneider Global Patient Affairs Lead Pfizer

10:20AM
-
10:40AM
Exhibition & Networking Coffee Break
Improve Strategy with Medical Expertise
10:40AM
-
11:20AM
Panel: Proactive communication of scientific and health economic information
  • Expert legislative and regulatory guidance relating to scientific communication by medical affairs personnel
  • An update on FDAMA 114 and the proactive communication of health economic information
  • Recent changes to communication of scientific and health economic information of pipeline products and indications
  • Recommendations from the Academy of Managed Care Pharmacy Partnership Forum on Pre-approval Information Exchange

Genentech Dana Evans Director for Patient Access, Collaboration and Exchange Genentech

Aetna Elizabeth Engelhardt Head of Specialty Strategy & Clinical Management Aetna

Academy of Managed Care Pharmacy (AMCP) Soumi Saha Assistant Director of Pharmacy & Regulatory Affairs Academy of Managed Care Pharmacy (AMCP)

11:20AM
-
11:50AM
Can Medical Affairs stay relevant in an era of emerging technologies to help the HCP?
  • Appreciate how healthcare professionals’ disease information needs are changing
  • Can technology help Medical to stay relevant, and meet increasingly high expectations of HCPs, or will it become a competitor?
  • Envisage what the future of medical could look like in this rapidly changing world of technology

Bristol-Myers Squibb Lav (Bobby) Parvathenani Specialty Medical Information Lead, US Medical Bristol-Myers Squibb

11:50AM
-
12:50PM
Exhibition, Networking & Work Lunch Roundtables
12:50PM
-
1:20PM
Make companion diagnostics a reality with more collaborative medical & scientific affairs
  • Discover how a coordinated approach between pharmaceutical and diagnostic medical affairs will lead to successful and rapid adoption of a companion diagnostic
  • Identify the various factors influencing the use of a companion diagnostic, and how this then influences the use and performance of the companion therapeutic
  • How to develop an implementation strategy that assures access to the companion diagnostic test at the day of drug launch

Roche Diagnostics Alan Wright Chief Medical Officer Roche Diagnostics

1:20PM
-
1:45PM
Execute a MSL strategy that navigates pro-active engagement and compliance
  • How to add customer value beyond communicating product information
  • Where should you invest to create impactful resources in a landscape of competitive sources of disease information?
  • Learn what steps to take to mature your model of MSL engagement

GlaxoSmithKline Diane McDowell Head, Global Scientific Affairs Oncology GSK

1:45PM
-
2:50PM
Panel: RWE Excellence within Medical Affairs
  • With the deluge of possible RWE sources, how do we develop analytic tools to assess the value of data
  • How can Medical Affairs facilitate the generation of new data?
  • How has the growth in evidence sources changed the importance of KOLs?
  • What compliant strategies can Medical Affairs use to communicate RWE?

Moderator: ghg_greyhealth_group Lynn Vos CEO ghg | greyhealth group

Astellas Shontelle Dodson Vice President, Medical Excellence/Medical Affairs Global Astellas

Sanofi Genzyme Paul Rowe Vice President, Global Medical Affairs Head, Airway/Respiratory Sanofi Genzyme

- Stanislav Glezer Former Vice President, Medical Affairs Novo Nordisk

2:50PM
-
3:10PM
Exhibition & Networking Coffee Break
Keynote Closing
3:10PM
-
3:20PM
Awards Finalist: Customer Innovator Award
3:20PM
-
3:50PM
The Impact of Value-Based Care: How It Will Transform Your Commercial Model
  • Explore the evolution of value-based care in the current healthcare ecosystem
  • Prepare to address the intersection of patient consumerism and value-based care to support a new definition of success
  • Examine key considerations to improve commercial uptake in a value-based care environment

McKesson Reagan Tully VP Marketing and Strategy McKesson

3:50PM
-
4:20PM
Squaring the Circle: how to drive performance and create success in a values culture
  • Explore the complex launch challenges faced by GSK’s newest vaccine Bexsero
  • Find out how GSK integrated Novartis Vaccines in its largest market, while implementing new commercial model changes in terms of HCP interaction
  • Understand how Patrick Desbiens led the integration of legacy and new vaccines teams and created a launch plan
  • Listen to Patrick explain the choices and the learnings on how to achieve success in a strong value-based culture from a year that saw GSK’s vaccine sales in the US increase by 12%

GSK Patrick Desbiens Senior Vice President, US Vaccines GSK

4:20PM
-
4:30PM
Awards Finalist: Most Valuable Pharma Collaboration
4:30PM
-
5:00PM
The Implementation Panel: From Words to Action, How to Become a Pharma Intrapreneur
  • Hear from our panel how you can make actionable change in your organizations through a structured process, behavioral engagement and prospective resource planning
  • Ensure open and reliable communication streams between departments, learn practical steps to break the ‘silo mentality’, and institute a collaboration approach that removes barriers long before they become a threat
  • Become the ‘Intrapreneurial change agent’ everyone respects, form alliances and manage innovation processes effectively to strengthen your organization from within

GSK Cheryl MacDiarmid SVP & Business Unit Head, Primary Care GSK

Sanofi Sheldon Koenig SVP & Head Cardiovascular Franchise Sanofi

Moderator eyeforpharma Paul Simms Chairman eyeforpharma

Day One

Keynote Opening
8:30AM - 8:35AM
Welcome Address

eyeforpharma Paul Simms Chairman eyeforpharma

8:35AM - 9:15AM
Ready for Healthcare Leadership - How Pharma embraces a New Customer Engagement Paradigm
  • Discuss industry implications of the shift to value-based care and learn how pioneering leaders position pharma companies to thrive in the complexity of the future healthcare ecosystem
  • Define the value of pharmaceutical innovation through the lens of the patient journey and lay the foundation to partner with healthcare delivery to support patient population management
  • Explore how to demonstrate transparency to build trust with patients, physicians and politicians

Otsuka Kabir Nath President & CEO Otsuka North America

Shire Perry Sternberg EVP & Head U.S. Commercial Shire

Kaiser Permanente Andrew McCulloch President- Kaiser Foundation Health Plan & Hospitals Northwest Region Kaiser Permanente

Moderator: National Health Council Marc Boutin CEO National Health Council

9:15AM - 9:45AM
Real Human Connection – A healthcare marketer’s new superpower
  • In today’s world, it appears that everything is “social” and “connected,” yet what does “being connected” even mean when it comes to healthcare?
  • Learn from real-world examples of how different healthcare stakeholders connect around patients and their needs

Shire Eric Cline Director Marketing US Neuroscience Business Unit Shire

UCB Dakar De La Cruz Senior Brand Manager Epilepsy Patients Initiatives UCB

AstraZeneca Pharmaceuticals Lise Hall Associate Director of Consumer Marketing Lung Cancer Franchise AstraZeneca Pharmaceuticals

Moderator: Snow Companies Chemelle Evans Vice President Snow Companies

9:45AM - 10:00AM
Awards Finalist Announcement: Most Valuable Patient Initiative
10:00AM - 10:30AM
Exhibition & Networking Coffee Break
10:30AM - 11:00AM
Patient Centricity as a Journey: Spearheading Cultural Change in a Global Pharma Organization
  • Hear leadership lessons and best practices on how to drive transformative cultural change, break organizational silos and foster a company-wide ethos of “patients first”
  • When vision meets determination: How can you initiate the success of a patient-focused mindset through a mix of top-down motivation and bottom-up actions?
  • Learn about the relationship between business growth and patient focus and how it impacts your stakeholder management

Merck Julie Gerberding EVP & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health Merck

11:00AM - 11:30AM
Delivering Impact through Customer-Centric Partnerships

The U.S. healthcare marketplace has undergone dramatic changes, including the shift in power away from physicians, and towards large payers and provider systems as they take on more risk and want demonstrable value. This has made pharma’s traditional model less relevant.

In response, pharmaceutical companies must reinvent the way they go to market by focusing on the unique needs of complex corporate customers to create a customer-centric engagement strategy, including:

  • Customer insights for complete local healthcare markets, including all stakeholders’ needs and interactions
  • Marketing and value propositions that stress the impact on health and value metrics
  • Expansion to dozens of roles that can work as a coordinated team
  • Objectives that align multiple functions in the organization

ZS Associates Partap Khedkar Principal ZS Associates

ZS Associates Paul Darling Principal ZS Associates

11:30AM - 12:10PM
Accelerating Bio-Pharmaceutical Innovation in the 21st Century: An Emergent Ecosystem
  • From Cambridge to San Diego: Hear life science leaders who shape the collaborative ecosystem that is shaping up for faster development of tomorrow’s cures amongst multiple stakeholders
  • “Distributed” Research: Harness the power of partnerships to accelerate development, standardize frameworks and build open platforms for the in- and outflow of knowledge between partners
  • Take charge of Innovation: Explore novel approaches to finance biopharmaceutical innovation for high-cost, breakthrough medications

Johnson & Johnson Melinda Richter Head JLabs Johnson & Johnson

Novo Nordisk Eddie Williams Former SVP BioPharmaceutical Novo Nordisk

Transcelerate Dalvir Gill CEO Transcelerate

12:10PM - 1:25PM
Exhibition & Networking Lunch Break
1:25PM - 1:35PM
Awards Finalist Announcement: Most Valuable HCP Initiative
1:35PM - 2:05PM
It's more than 'the Right Thing to Do': Embrace Patient Centricity as your Key Commercial Focus
  • Learn about the relationship between business growth and patient focus and how the sweet spot impacts your stakeholder management
  • Steer your company's patient focus out of the buzzword land through measurement, cultural training, and executive commitment
  • Explore metrics to reveal the impact of patient-centric initiatives, including performance indicators that can guide your line management
  • Understand where to expand your business offering and customer perspective to truly service patients with everything you do

Pfizer Innovative Health Andy Schmeltz Senior Vice President of Patient & Health Impact Pfizer Innovative Health

2:05PM - 3:10PM
Pharma-Only Workshops
3:10PM - 3:30PM
Exhibition & Networking Coffee Break
Medical Affairs
Define the New Medical Model
3:30PM - 3:35PM
Chairman Opening
3:35PM - 4:00PM
Make medical the link between R&D and commercial
  • Discuss how and when Medical should become involved in early-stage projects and Life-cycle management
  • Explore the important role of patient centricity as an essential foundational component for collaboration
  • Identify opportunities to improve partnership effectiveness

Sanofi Genzyme Paul Rowe Vice President, Global Medical Affairs Head, Airway/Respiratory Sanofi Genzyme

4:00PM - 4:30PM
The Good, The Bad and the Necessary
  • A review of success rates in recent drug launches
  • Look at where launches haven’t gone well and where RWE could have played a role in mitigating this… The Bad
  • Building an Integrated Medical Plan to prepare for success. “Begin with the End in Mind”… The Good
  • The resource versus demand challenge and the consequent benefit of outsourcing… The Necessary

INC Research Janet Baldwin Vice President, Real World and Late Phase INC Research

4:30PM - 5:10PM
Panel: Define a new Medical operating model to align with Commercial, Market Access and R&D
  • Understand what internal stakeholders think about their relationship with Medical and the emergence of Medical as a strategic partner
  • Where should medical reside - independently, within R&D, or Commercial?
  • Create a reporting and management structure that meets the needs for a new approach to Medical Affairs

GlaxoSmithKline Kate Knobil Chief Medical Officer, Pharmaceuticals GSK

Medical Affairs Professional Society Kirk Shepard President Medical Affairs Professional Society;
Eisai Pharma & Senior Vice President, Head of Global Medical Affairs Oncology Eisai Pharma

Amgen Rosh Dias Vice President, Global Scientific Affairs Amgen

5:10PM - 5:40PM
Pharma Collaboration for Transparent Medical Information
  • HCPs need quick, relevant, accurate, scientifically-balanced medical information to enhance patient care
  • phactMI is a consortium comprised of MI departments of multiple pharmaceutical companies to address this need
  • phactMI.org provides an easy access “one stop” to information on drug interactions, stability/compatibility, and dosage and administration… and HCPs can contact and engage with dedicated MI specialists

phactMI Patrick Reilly CEO phactMI

5:40PM - 6:05PM
The Doctor is in (and out): Medical Affairs’ evolution from an internal role to an external one
  • Understand the evolving role of medical affairs in pharma
  • Explore the benefits and challenges of using internal medical spokespeople for external communications
  • Embrace the potential for medical affairs’ new role through a case study

GlaxoSmithKline Leonard Friedland Vice President, Director Scientific Affairs and Public Policy, Vaccines North America GSK

6:05PM - 7:30PM
Exhibition & Networking, Awards Nomination Finalists: Lifetime Achievement Award

Pre-order your event brochure

Full speaker list • Full conference agenda • Audience breakdown

Day Two

Medical Affairs
8:30AM
-
8:35AM
Chairman Opening
8:35AM
-
9:00AM
Collaborate with Commercial to create a compliant and patient-focused Medical Affairs strategy
  • Identify appropriate cross-functional stakeholders for coordination and alignment
  • Ensure independence and integrity of Medical Affairs and Commercial functions
  • Enable effective and compliant information sharing/communication

Astellas Pharma Shontelle Dodson Vice President, Medical Excellence/Medical Affairs Global Astellas

Astellas Karen Lowney Executive Director, Global Compliance, Privacy & Transparency Astellas

Recruit and Manage the new Medical Affairs
9:00AM
-
9:30AM
Hire the right skillsets for the new medical affairs paradigm
  • Define recruitment and training strategies to meet your medical affairs needs
  • Build soft business skills within medical specialist talent
  • Create a team that can execute RWE and data-centric engagement strategies

- Stanislev Glezer former Vice President, Medical Affairs Novo Nordisk

9:30AM
-
9:55AM
The Competent Medical Affairs Professional
  • Discuss the emerging role of professional competencies (applied knowledge, skills and behaviors) in bridging the business needs with the scientific rigor of the medicines development process
  • Understand how to benchmark the proposed competency profiles in medical affairs
  • Appreciate the value of a multi-sectorial collaboration (academia, professional associations, pharmaceutical industry) to improving performance in the Medical Affairs function

IFAPP Honorio Silva President IFAPP

9:55AM
-
10:20AM
How to create a patient-centric Medical Affairs unit
  • Define best practice to engage patients, understand their needs and create patient-centric medical information exchange
  • How to work progressively with patients to gather data
  • Can Medical Affairs become the patient centricity function?

Pfizer Roslyn Schneider Global Patient Affairs Lead Pfizer

10:20AM
-
10:40AM
Exhibition & Networking Coffee Break
Improve Strategy with Medical Expertise
10:40AM
-
11:20AM
Panel: Proactive communication of scientific and health economic information
  • Expert legislative and regulatory guidance relating to scientific communication by medical affairs personnel
  • An update on FDAMA 114 and the proactive communication of health economic information
  • Recent changes to communication of scientific and health economic information of pipeline products and indications
  • Recommendations from the Academy of Managed Care Pharmacy Partnership Forum on Pre-approval Information Exchange

Genentech Dana Evans Director for Patient Access, Collaboration and Exchange Genentech

Aetna Elizabeth Engelhardt Head of Specialty Strategy & Clinical Management Aetna

Academy of Managed Care Pharmacy (AMCP) Soumi Saha Assistant Director of Pharmacy & Regulatory Affairs Academy of Managed Care Pharmacy (AMCP)

11:20AM
-
11:50AM
Can Medical Affairs stay relevant in an era of emerging technologies to help the HCP?
  • Appreciate how healthcare professionals’ disease information needs are changing
  • Can technology help Medical to stay relevant, and meet increasingly high expectations of HCPs, or will it become a competitor?
  • Envisage what the future of medical could look like in this rapidly changing world of technology

Bristol-Myers Squibb Lav (Bobby) Parvathenani Specialty Medical Information Lead, US Medical Bristol-Myers Squibb

11:50AM
-
12:50PM
Exhibition, Networking & Work Lunch Roundtables
12:50PM
-
1:20PM
Make companion diagnostics a reality with more collaborative medical & scientific affairs
  • Discover how a coordinated approach between pharmaceutical and diagnostic medical affairs will lead to successful and rapid adoption of a companion diagnostic
  • Identify the various factors influencing the use of a companion diagnostic, and how this then influences the use and performance of the companion therapeutic
  • How to develop an implementation strategy that assures access to the companion diagnostic test at the day of drug launch

Roche Diagnostics Alan Wright Chief Medical Officer Roche Diagnostics

1:20PM
-
1:45PM
Execute a MSL strategy that navigates pro-active engagement and compliance
  • How to add customer value beyond communicating product information
  • Where should you invest to create impactful resources in a landscape of competitive sources of disease information?
  • Learn what steps to take to mature your model of MSL engagement

GlaxoSmithKline Diane McDowell Head, Global Scientific Affairs Oncology GSK

1:45PM
-
2:50PM
Panel: RWE Excellence within Medical Affairs
  • With the deluge of possible RWE sources, how do we develop analytic tools to assess the value of data
  • How can Medical Affairs facilitate the generation of new data?
  • How has the growth in evidence sources changed the importance of KOLs?
  • What compliant strategies can Medical Affairs use to communicate RWE?

Moderator: ghg_greyhealth_group Lynn Vos CEO ghg | greyhealth group

Astellas Shontelle Dodson Vice President, Medical Excellence/Medical Affairs Global Astellas

Sanofi Genzyme Paul Rowe Vice President, Global Medical Affairs Head, Airway/Respiratory Sanofi Genzyme

- Stanislav Glezer Former Vice President, Medical Affairs Novo Nordisk

2:50PM
-
3:10PM
Exhibition & Networking Coffee Break
Keynote Closing
3:10PM
-
3:20PM
Awards Finalist: Customer Innovator Award
3:20PM
-
3:50PM
The Impact of Value-Based Care: How It Will Transform Your Commercial Model
  • Explore the evolution of value-based care in the current healthcare ecosystem
  • Prepare to address the intersection of patient consumerism and value-based care to support a new definition of success
  • Examine key considerations to improve commercial uptake in a value-based care environment

McKesson Reagan Tully VP Marketing and Strategy McKesson

3:50PM
-
4:20PM
Squaring the Circle: how to drive performance and create success in a values culture
  • Explore the complex launch challenges faced by GSK’s newest vaccine Bexsero
  • Find out how GSK integrated Novartis Vaccines in its largest market, while implementing new commercial model changes in terms of HCP interaction
  • Understand how Patrick Desbiens led the integration of legacy and new vaccines teams and created a launch plan
  • Listen to Patrick explain the choices and the learnings on how to achieve success in a strong value-based culture from a year that saw GSK’s vaccine sales in the US increase by 12%

GSK Patrick Desbiens Senior Vice President, US Vaccines GSK

4:20PM
-
4:30PM
Awards Finalist: Most Valuable Pharma Collaboration
4:30PM
-
5:00PM
The Implementation Panel: From Words to Action, How to Become a Pharma Intrapreneur
  • Hear from our panel how you can make actionable change in your organizations through a structured process, behavioral engagement and prospective resource planning
  • Ensure open and reliable communication streams between departments, learn practical steps to break the ‘silo mentality’, and institute a collaboration approach that removes barriers long before they become a threat
  • Become the ‘Intrapreneurial change agent’ everyone respects, form alliances and manage innovation processes effectively to strengthen your organization from within

GSK Cheryl MacDiarmid SVP & Business Unit Head, Primary Care GSK

Sanofi Sheldon Koenig SVP & Head Cardiovascular Franchise Sanofi

Moderator eyeforpharma Paul Simms Chairman eyeforpharma


Join the Medical Affairs community

Stay updated, receive the latest content and download your brochure.

If you are interested in getting involved in the eyeforpharma Medical Affairs USA summit, please contact me on the details below.

James Mackintosh

James Mackintosh

Global project Director
eyeforpharma

Phone (US): +1800 814 3459 7163

Phone (Global): +44 (0) 207 375 7163

Email: jmackintosh@eyeforpharma.com

Pre-order the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown